Who owns ADC Therapeutics SA?
- Ticker: ADCT
- CUSIP Number: h0036k147
Tip: Access positions for across all investors
Analyze quarterly positions in ADC Therapeutics SA with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of ADC Therapeutics SA stock
Who bought or sold ADC Therapeutics SA this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Redmile Group | 15M | $69M | 0% | Mar 2024 |
|
| Prosight Management | 7.1M | $32M | 31% | Mar 2024 |
|
| Morgan Stanley | 2.7M | $12M | 310% | Mar 2024 |
|
| Goldman Sachs Group | 1.5M | $6.9M | 6% | Mar 2024 |
|
| Bank of America Corporation | 1.2M | $5.4M | -22% | Mar 2024 |
|
| Millennium Management | 1.0M | $4.5M | -62% | Mar 2024 |
|
| Citadel Advisors | 1.0M | $4.5M | -46% | Mar 2024 |
|
| Adage Capital Partners GP | 1.0M | $4.5M | 100% | Mar 2024 |
|
| Vantage Consulting Group | 851k | $3.8M | 0% | Mar 2024 |
|
| Blue Owl Capital Holdings | 734k | $3.3M | 0% | Mar 2024 |
|
| Monashee Investment Management | 500k | $2.2M | 100% | Mar 2024 |
|
| GCM Grosvenor Holdings | 411k | $1.8M | 0% | Mar 2024 |
|
| Marshall Wace | 243k | $1.1M | 1013% | Mar 2024 |
|
| Susquehanna International | 157k | $706k | 100% | Mar 2024 |
|
| Cubist Systematic Strategies | 121k | $542k | 100% | Mar 2024 |
|
| Sanibel Captiva Trust Company | 103k | $463k | 100% | Mar 2024 |
|
| Miracle Mile Advisors | 85k | $379k | 0% | Mar 2024 |
|
| Hennion & Walsh Asset Management | 71k | $317k | 7% | Mar 2024 |
|
| Two Sigma Investments | 55k | $247k | 100% | Mar 2024 |
|
| DLK Investment Management | 33k | $149k | 0% | Mar 2024 |
|
| Jane Street | 27k | $121k | -73% | Mar 2024 |
|
| D. E. Shaw & Co | 27k | $121k | 100% | Mar 2024 |
|
| XTX Topco | 25k | $112k | -63% | Mar 2024 |
|
| Balyasny Asset Management | 24k | $107k | 100% | Mar 2024 |
|
| Saxony Capital Management | 21k | $93k | 0% | Mar 2024 |
|
| Moneta Group Investment Advisors | 20k | $32k | 0% | Dec 2023 |
|
| Commonwealth Equity Services | 19k | $84k | -5% | Mar 2024 |
|
| Simplex Trading | 15k | $66k | 1151% | Mar 2024 |
|
| Advisor Group Holdings | 8.0k | $36k | -43% | Mar 2024 |
|
| Group One Trading | 4.8k | $22k | 114% | Mar 2024 |
|
| Royal Bank of Canada | 3.0k | $14k | -25% | Mar 2024 |
|
| Eagle Bay Advisors | 670.00 | $3.0k | 100% | Mar 2024 |
|
| Pnc Financial Services | 250.00 | $1.1k | 0% | Mar 2024 |
|
| UBS Group | 51.00 | $229.500000 | 100% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 20.00 | $90.000000 | 100% | Mar 2024 |
|
Who sold out of ADC Therapeutics SA?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sio Capital Management | Sep 2023 | 3.3M | $3.0M |
| AlphaCentric Advisors | Sep 2023 | 1.1M | $958k |
| BlackRock | Sep 2023 | 530k | $475k |
| Acadian Asset Management | Sep 2023 | 156k | $138k |
| Indie Asset Partners | Dec 2023 | 93k | $154k |
| Hrt Financial | Dec 2023 | 80k | $132k |
| ELCO Management | Sep 2023 | 22k | $19k |
| Gladius Capital Management | Sep 2023 | 20k | $18k |
| Tower Research Capital | Sep 2023 | 4.1k | $3.7k |
| FMR | Sep 2023 | 1.3k | $1.2k |
| Focused Wealth Management | Dec 2023 | 300.00 | $498.000000 |
| Qube Research & Technologies | Sep 2023 | 207.00 | $186.010200 |